Cancer is not a standalone disease; it often intersects with other chronic conditions, creating complex medical challenges. The co-occurrence of cancer and diseases such as diabetes, cardiovascular conditions, and autoimmune disorders can significantly impact diagnosis, treatment, and outcomes. For example, patients with diabetes may experience altered cancer progression or treatment side effects due to insulin resistance. Similarly, cardiovascular diseases can complicate cancer treatments that affect heart function, necessitating careful management. Research in cancer's intersection with other diseases is crucial to developing integrated treatment approaches that address multiple health concerns simultaneously. This growing area of study aims to enhance personalized medicine, offering patients more effective, tailored therapies that take into account the interplay between cancer and co-existing conditions. Such research is pivotal in improving survival rates and quality of life for patients navigating these multifaceted health challenges.
Title : RNA binding proteins in the pathogenesis of pediatric cancer
Atif A Ahmed, University of Washington-Seattle Children’s Hospital, United States
Title : A novel mRNA genomic technology for precision medicine, early cancer diagnosis, prognosis, treatment follow-up and cancer gene therapy
Rajvir Dahiya, University of California San Francisco, United States
Title :
Jianhua Luo, University of Pittsburgh, United States
Title : Biosensor-based detection of cancer biomarkers
Michael Thompson, University of Toronto, Canada
Title : Principles of oral rehabilitation in H&N cancer patients
Pietro Salvatori, Independent H&N Surgeon, Italy
Title :
Marika Crohns, Impactful Innovations Management Consultants LLC, United Arab Emirates